Cargando…

Pramipexole Extended Release: A Novel Treatment Option in Parkinson's Disease

Pramipexole, the most commonly prescribed dopamine agonist worldwide, meanwhile serves as a reference substance for evaluation of new drugs. Based on numerous clinical data and vast experiences, efficacy and safety profiles of this non-ergoline dopamine agonist are well characterized. Since October...

Descripción completa

Detalles Bibliográficos
Autores principales: Eisenreich, Wolfram, Sommer, Bernd, Hartter, Sebastian, Jost, Wolfgang H.
Formato: Texto
Lenguaje:English
Publicado: SAGE-Hindawi Access to Research 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3010659/
https://www.ncbi.nlm.nih.gov/pubmed/21209705
http://dx.doi.org/10.4061/2010/612619